Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-022813
Filing Date
2013-05-24
Accepted
2013-05-24 17:29:15
Documents
1
Period of Report
2013-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 14860
  Complete submission text file 0001140361-13-022813.txt   17284
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35919 | Film No.: 13872988

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35919 | Film No.: 13872987

Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address 11080 ROSELLE STREET SAN DIEGO CA 92121 8583342100
AMBIT BIOSCIENCES CORP (Issuer) CIK: 0001131543 (see all company filings)

EIN.: 330909648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 212-749-6400
OrbiMed Capital GP III LLC (Reporting) CIK: 0001432241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35919 | Film No.: 13872989